Pell Bio-Med Technology Co., Ltd. (TPE:6949)

Pell Bio-Med Technology Statistics

Total Valuation

TPE:6949 has a market cap or net worth of TWD 25.63 billion. The enterprise value is 25.32 billion.

Market Cap	25.63B
Enterprise Value	25.32B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6949 has 58.31 million shares outstanding. The number of shares has increased by 12.03% in one year.

Current Share Class	58.31M
Shares Outstanding	58.31M
Shares Change (YoY)	+12.03%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	16.72%
Owned by Institutions (%)	n/a
Float	27.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	934.24
PB Ratio	22.41
P/TBV Ratio	24.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-71.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-40.32

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.31.

Current Ratio	2.51
Quick Ratio	1.95
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.56
Interest Coverage	-93.98

Financial Efficiency

Return on equity (ROE) is -28.12% and return on invested capital (ROIC) is -15.26%.

Return on Equity (ROE)	-28.12%
Return on Assets (ROA)	-13.75%
Return on Invested Capital (ROIC)	-15.26%
Return on Capital Employed (ROCE)	-30.08%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	6.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +435.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+435.98%
50-Day Moving Average	321.41
200-Day Moving Average	170.97
Relative Strength Index (RSI)	61.01
Average Volume (20 Days)	402,826

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6949 had revenue of TWD 27.43 million and -356.15 million in losses. Loss per share was -6.11.

Revenue	27.43M
Gross Profit	-5.36M
Operating Income	-380.98M
Pretax Income	-367.02M
Net Income	-356.15M
EBITDA	-362.01M
EBIT	-380.98M
Loss Per Share	-6.11

Balance Sheet

The company has 761.48 million in cash and 351.10 million in debt, giving a net cash position of 410.39 million or 7.04 per share.

Cash & Cash Equivalents	761.48M
Total Debt	351.10M
Net Cash	410.39M
Net Cash Per Share	7.04
Equity (Book Value)	1.14B
Book Value Per Share	17.91
Working Capital	593.53M

Cash Flow

In the last 12 months, operating cash flow was -287.56 million and capital expenditures -340.38 million, giving a free cash flow of -627.95 million.

Operating Cash Flow	-287.56M
Capital Expenditures	-340.38M
Free Cash Flow	-627.95M
FCF Per Share	-10.77

Margins

Gross Margin	-19.52%
Operating Margin	-1,388.81%
Pretax Margin	-1,337.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6949 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.03%
Shareholder Yield	n/a
Earnings Yield	-1.39%
FCF Yield	-2.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6949 has an Altman Z-Score of 5.95 and a Piotroski F-Score of 3.

Altman Z-Score	5.95
Piotroski F-Score	3